Diabetes Board decisions

The Board denied the claim for service connection for bilateral pes planus, finding that it preexisted service and did not increase in disability. The claims for ischemic heart disease, diabetes mellitus, peripheral neuropathy, hypertension, and pes planus were remanded for further development.

The Board denied service connection for diabetes mellitus type II and bilateral lower extremity neuropathy, finding that the evidence did not support a causal relationship between these conditions and the Veteran's active military service.

The Board denied the veteran's appeals for service connection due to untimely filings.

The Board dismissed the claims for service connection for bilateral hearing loss and tinnitus due to untimely appeals, while remanding the claims for diabetes mellitus type II, GERD, high blood pressure, and urinary frequency for further development.

The Board denied service connection for various conditions, including GERD, bilateral vision impairment, chronic kidney disease, diabetes mellitus, erectile dysfunction, headaches, heart disability, hypertension, left upper extremity neuropathy, right upper extremity neuropathy, an acquired psychiatric disorder, a right hip condition, sleep apnea, and urinary frequency.

The Board granted increased ratings for right and left upper extremity neuropathy, right and left lower extremity diabetic peripheral neuropathy, and hypothyroidism, as well as a TDIU from May 1, 2018 to September 19, 2019. The Board denied increased ratings for diabetes mellitus, type II, kidney disease stage III with hypertension (kidney disease with hypertension), tinnitus, and service connection for migraines.

The Board granted service connection for chronic lymphocytic leukemia, coronary artery disease with atrial fibrillation, diabetes mellitus type II, and Parkinson's disease based on presumptive service connection due to herbicide exposure.

The Board granted service connection for diabetes mellitus, Type II, resolving any reasonable doubt in favor of the Veteran and finding a relationship to his conceded in-service exposure to asbestos.

The Board granted service connection for diabetes mellitus, coronary artery disease (CAD), and Parkinson's disease based on herbicide exposure during the Veteran's service.

The Board granted service connection for type II diabetes mellitus and hypertension, finding that both conditions are related to the Veteran's military service.

The Board denied service connection for diabetes mellitus and remanded the claim for an acquired psychiatric disorder due to insufficient evidence.

The Board granted service connection for the cause of death, determining that it is at least as likely as not that the Veteran's fatal conditions were caused by his military service.

The Board granted service connection for diabetes mellitus, type II, resolving reasonable doubt in the Veteran's favor.

The Board denied service connection for various disabilities, including abnormal weight loss, a bladder disability, blockage of the neck arteries, and others. The evidence did not support a finding that any of these conditions were related to the Veteran's active service.

The Board remands the claims for service connection for an eye condition, hearing loss, heart disease, arthritis, and diabetes due to a regulatory duty to assist error.

The Board remands the claims for service connection for prostate cancer, diabetes mellitus type II, and diabetic neuropathy of the upper and lower extremities due to a need for clarification regarding the Veteran's exposure to Agent Orange.

The Board granted a 100 percent disability rating for PTSD and denied an earlier effective date. The claims for service connection for various conditions were remanded.

The Board granted service connection for diabetes mellitus, type II and hypertension based on the evidence of record at the time of the July 2025 rating decision.

The Board denied service connection for chronic fatigue syndrome (CFS) and remanded claims for a disability manifested by shortness of breath, hypertension, diabetes mellitus, type II, and left lower neuropathy.

The Board granted reconsideration of the issues of entitlement to service connection for basal cell carcinoma, an acquired psychiatric disorder, and bilateral upper and lower extremity diabetic peripheral neuropathy. The claims for these conditions were previously denied but are now being readjudicated due to new evidence.